[back]

Lion Biotechnologies, Inc.

Period: Nov 14, 2013 to Apr 10, 2017

Lead Plaintiff Deadline: Jun 13, 2017 + Deadline passed

Summary of Case:

Scott+Scott, Attorneys at Law, LLP ("Scott+Scott"), a national shareholder and consumer rights litigation firm, reminds investors that June 13, 2017 is the last day to file lead plaintiff papers in the securities lawsuit against Lion Biotechnologies, Inc. ("Lion" or the "Company") (NASDAQ: LBIO).  The class action is on behalf of a class consisting of all persons who purchased Lion common stock between November 14, 2013 and April 10, 2017, both dates inclusive (the "Class Period").  If you are a Lion shareholder, you are encouraged to contact Scott+Scott for more information.

Lion focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells.  Lion shares are traded on the NASDAQ stock exchange under the ticker symbol "LBIO."

The complaint alleges that throughout the Class Period, Defendants made false and/or misleading statements and/or failed to disclose that: (1) Lion Biotechnologies, through its former CEO Manish Singh, engaged in a scheme to mislead investors by commissioning over 10 internet publications and 20 widely distributed emails promoting Lion Biotechnologies to potential investors that purported to be independent from the company when, in fact, they were paid promotions; (2) former CEO Singh engaged a stock promotion firm to pay writers to publish articles about Lion Biotechnologies on investment websites as well as to coordinate the distribution of articles to thousands of electronic mailboxes; (3) former CEO Singh actively participated in the promotional work for Lion Biotechnologies and understood that the promotion firm was using writers who would not disclose that Lion Biotechnologies was indirectly compensating them for their publications; and (4) as a result, defendants' public statements were materially false and misleading at all relevant times.  When the true details entered the market, the lawsuit claims that investors suffered damages.

What You Can Do

If you purchased Lion shares, you may have legal claims against the Company.  If you want to discuss filing lead plaintiff papers, or have questions about your legal rights, please contact attorney Joseph Pettigrew at (844) 818-6982, or at jpettigrew@scott-scott.com.  Shareholders have until June 13, 2017 to petition the court for lead plaintiff status.

About Scott+Scott, Attorneys at Law, LLP

Scott+Scott has significant experience in prosecuting major securities, antitrust, and employee retirement plan actions throughout the United States.  The firm represents pension funds, foundations, individuals, and other entities worldwide with offices in New York, London, Connecticut, California, and Ohio.

CONTACT:

Joseph Pettigrew

Scott+Scott, Attorneys at Law, LLP

(844) 818-6982

jpettigrew@scott-scott.com

If you purchased this company's shares during the Class Period and suffered a loss or for further information about the case, please review the links below.

[back]